Biotechnology Stocks II Performance Guide: Editas Medicine, Inc. (EDIT)
EDIT has no dividends.
Table and Chart of EDIT Performance
See what a $1,000 investment in EDIT is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| EDIT Returns | |
|---|---|
| Start Date | Mar-31-2016 |
| Start Price | $34.54 |
| End Date | May-16-2024 |
| End Price | $5.89 |
| # Prices | 99 |
| Min Date | Apr-30-2024 |
| Min Price | $5.21 |
| Max Date | Dec-31-2020 |
| Max Price | $70.11 |
| Total Return | -82.95% |
| Annualized Return | -19.30% |
| Current Value of $1,000 Purchase | $171 |
| Number Returns | 4,851 |
| Average Return | -7.65% |
| Number Profitable Returns | 1,735 |
| Percent Profitable Returns | 35.77% |
| Number Unprofitable Returns | 3,116 |
| Percent Unprofitable Returns | 64.23% |
| Profitable to Unprofitable Returns Ratio | 0.56 |
| EDIT Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $493,428,000 |
| Beta | 2.080 | Price to Sales | 6.50 |
| Earnings per Share | $-2.0700 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 1.455 |
| PRICE DATA | |
| 52 Week High | $11.91 |
| 52 Week Low | $4.91 |
| Analyst Target Price | $15.36 |
| 50-Day Moving Average | $6.66 |
| 200-Day Moving Average | $8.11 |
| FINANCIAL DATA | |
| Revenue per Share | $0.876 |
| Revenue | $69,407,000 |
| Profit Margin | -239.4% |
| Return on Equity | -54.3% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
EDIT Compare Returns with S&P 500
EDIT Trendline Chart
EDIT Moving Average Chart
EDIT Stock Return Map - See Patterns of Gains and Losses
EDIT Stock Returns/Purchase Dates